Related Experiment Video
Updated: May 23, 2026

Use of a Central Venous Line for Fluids, Drugs and Nutrient Administration in a Mouse Model of Critical Illness
Published on: May 2, 2017
Liver cirrhosis in the medical critical care patient
G Biancofiore1, G Auzinger, S Mandell
1Anestesia e Rianimazione SSN, Azienda Ospedaliera Universitaria Pisana, Pisa, Italia. g.biancofiore@med.unipi.it
Abstract:
Critically ill cirrhotic patients are characterized by unique and complicated clinical scenarios related to some characteristic and clear-cut pathophysiological features of their chronic end-stage liver disease that challenge Intensive Care Unit (ICU) physicians with several management problems. This class of patients may require admission to the ICU because of decompensation of their pre-existing liver disease or due to medical problems independent of cirrhosis as pneumonia, trauma or surgery. Either way, it is acknowledged that, when feasible, without definitive treatment by way of liver transplantation, cirrhosis is an independent predictor of poor outcome in critically ill patients. In fact, cerebral, cardiopulmonary and kidney dysfunctions as well as portal vein hypertension, ascites and gastrointestinal bleeding can make the course of these patients very complicated and may further affect their outcome. Despite some improvement that was recently reported, patients with decompensated cirrhosis pose to ICU physicians several and, sometimes, dramatic dilemmas in terms of therapeutic strategies and efficacy of the treatments also due to the lack of large specific studies on this particular class of patients. This review will focus on kidney, cardiopulmonary and cerebral complications of severe cirrhosis as well as those related to portal hypertension and their management.
Related Concept Videos
Cirrhosis I: Introduction
Cirrhosis II: Pathophysiology
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test